#UNICHEMLAB : Co. informs tentative approval for ANDA from USFDA for Sitagliptin tablet USP , 25 Mg , 50 Mg & 100 Mg .of Merck Sharpe & Dohme corp
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
UNICHEMLAB
333.65
-1.8 (-0.54%)
Updated 03:28 23/07 IST
UNICHEMLAB Buy or Sell - FrontPage Forums
1 Users have submitted 1 trade ideas of Rs. 5,055 for UNICHEMLAB
Disclaimer100% Bullish
0% Bearish
UNICHEMLAB Buy or Sell - Brokerage Reports
No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
UNICHEMLAB Ratings
Long term UNICHEMLAB rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
0/5 (0 Ratings)0
Find answers to all your questions on live UNICHEMLAB message board: Is UNICHEMLAB buy or sell? Should I buy UNICHEMLAB shares? Why are UNICHEMLAB shares falling? Should I invest in UNICHEMLAB stock?
- Home
- UNICHEMLAB Forum
UNICHEMLAB Share Price Discussion
T
Reputation: 35,645 • Mar 5 1:12 AM
Stocks in the news
Wipro: The company has signed an agreement to acquire Capco, a global management and technology consultancy providing digital, consulting and technology services to financial institutions in America, Europe and the Asia Pacific.
Heranba Industries: The company ...
Read more...
2
Reply
N
Reputation: 15,178 • Feb 19 10:03 AM
Unichem Laboratories Gets USFDA Nod For Plaque Psoriasis Treatment Drug
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Moneycontrol
Like
Reply
N
Reputation: 15,178 • Feb 19 10:03 AM
Unichem Laboratories Share Price Rises 8% On US FDA Approval For The Apremilast Tablets
The share touched a 52-week high of Rs 332.40 and a 52-week low of Rs 75.10 on 08 February 2021 and 24 March 2020, respectively.
The share touched a 52-week high of Rs 332.40 and a 52-week low of Rs 75.10 on 08 February 2021 and 24 March 2020, respectively.
Moneycontrol
Like
Reply
N
Reputation: 15,178 • Feb 19 5:26 AM
Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drug
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
The Economic Times
Like
Reply
N
Reputation: 15,178 • Feb 2 4:18 AM
Like
Reply
N
Reputation: 15,178 • Feb 2 4:08 AM
Like
Reply
N
Reputation: 15,178 • Jan 27 11:08 AM
Unichem Laboratories Gets USFDA Nod To Market Generic Capsules
The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.
The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.
Moneycontrol
Like
Reply
N
Reputation: 15,178 • Jan 27 10:01 AM
Unichem Labs gets USFDA nod to market generic capsules
The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.
The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.
The Economic Times
Like
Reply
N
Reputation: 15,178 • Jan 13 7:58 AM
Unichem Laboratories Gets USFDA Nod To Market Generic Celecoxib Capsules
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE.
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE.
Moneycontrol
Like
Reply
N
Reputation: 15,178 • Jan 13 7:36 AM
Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsules
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE.
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE.
The Economic Times
Like
Reply
N
Reputation: 15,178 • Dec 1, 2020 3:48 AM
Unichem Laboratories shares rise 4% on USFDA approval for blood pressure tablets
The share touched its 52-week high Rs 304.20 and 52-week low Rs 75.10 on 04 August, 2020 and 24 March, 2020, respectively.
The share touched its 52-week high Rs 304.20 and 52-week low Rs 75.10 on 04 August, 2020 and 24 March, 2020, respectively.
Moneycontrol
1
Reply
T
Reputation: 35,645 • Nov 6, 2020 1:58 AM
TradeAdda in UNICHEMLAB#UNICHEMLAB For Educational Purposes only. #Tr...
View Failed if bought still holding CLBS sl 229 and exit on Rise
#Update
For Educational Purposes only.
#TradeAdda
Like
Reply
N
Reputation: 15,178 • Nov 3, 2020 3:28 AM
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
UNICHEMLAB Share Price - Technicals
- NewsBotFeb 19 10:03 AMUnichem Laboratories Gets USFDA Nod For Plaque Psoriasis Treatment DrugMoneycontrolNewsBotFeb 19 10:03 AMUnichem Laboratories Share Price Rises 8% On US FDA Approval For The Apremilast TabletsMoneycontrolNewsBotFeb 19 5:26 AMUnichem Laboratories gets USFDA nod for plaque psoriasis treatment drugThe Economic TimesNewsBotFeb 2 4:18 AMNewsBotFeb 2 4:08 AMNewsBotJan 27 11:08 AMUnichem Laboratories Gets USFDA Nod To Market Generic CapsulesMoneycontrolNewsBotJan 27 10:01 AMUnichem Labs gets USFDA nod to market generic capsulesThe Economic TimesNewsBotJan 13 7:58 AMUnichem Laboratories Gets USFDA Nod To Market Generic Celecoxib CapsulesMoneycontrolNewsBotJan 13 7:36 AMUnichem Labs gets American drug regulator's nod to market generic Celecoxib capsulesThe Economic TimesNewsBotDec 1, 2020 3:48 AMUnichem Laboratories shares rise 4% on USFDA approval for blood pressure tabletsMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.